Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016 (2016), Article ID 4814702, 6 pages
http://dx.doi.org/10.1155/2016/4814702
Research Article

Differential Proteomics Analysis of Colonic Tissues in Patients of Slow Transit Constipation

Zhongnan Hospital of Wuhan University, Department of Colorectal & Anal Surgery, Clinical Center of Intestinal and Colorectal Diseases of Hubei Province, Key Laboratory of Intestinal & Colorectal Diseases of Hubei Province, Wuhan University, No. 169, Donghu Road, Wuchang District, Wuhan, Hubei 430071, China

Received 2 March 2016; Accepted 11 April 2016

Academic Editor: Terry K. Smith

Copyright © 2016 Songlin Wan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Polymeros, I. Beintaris, A. Gaglia et al., “Partially hydrolyzed guar gum accelerates colonic transit time and improves symptoms in adults with chronic constipation,” Digestive Diseases and Sciences, vol. 59, no. 9, pp. 2207–2214, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. L. Leung, T. Riutta, J. Kotecha, and W. Rosser, “Chronic constipation: an evidence-based review,” Journal of the American Board of Family Medicine, vol. 24, no. 4, pp. 436–451, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. S. M. Mugie, M. A. Benninga, and C. Di Lorenzo, “Epidemiology of constipation in children and adults: a systematic review,” Best Practice and Research: Clinical Gastroenterology, vol. 25, no. 1, pp. 3–18, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Lembo and M. Camilleri, “Current concepts: chronic constipation,” The New England Journal of Medicine, vol. 349, no. 14, pp. 1360–1368, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Singh, S. Heady, E. Coss-Adame, and S. S. C. Rao, “Clinical utility of colonic manometry in slow transit constipation,” Neurogastroenterology and Motility, vol. 25, no. 6, pp. 487–495, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. C. H. Knowles, S. M. Scott, C. Rayner et al., “Idiopathic slow-transit constipation: an almost exclusively female disorder,” Diseases of the Colon and Rectum, vol. 46, no. 12, pp. 1716–1717, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. D. M. Preston and J. E. Lennard-Jones, “Severe chronic constipation of young women: ‘idiopathic slow transit constipation’,” Gut, vol. 27, no. 1, pp. 41–48, 1986. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Camilleri, W. Grant Thompson, J. W. Fleshman, and J. H. Pemberton, “Clinical management of intractable constipation,” Annals of Internal Medicine, vol. 121, no. 7, pp. 520–528, 1994. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Bouchoucha, G. Devroede, P. Arhan et al., “What is the meaning of colorectal transit time measurement?” Diseases of the Colon & Rectum, vol. 35, no. 8, pp. 773–782, 1992. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Emmanuel, M. Cools, L. Vandeplassche, and R. Kerstens, “Prucalopride improves bowel function and colonic transit time in patients with chronic constipation: an integrated analysis,” The American Journal of Gastroenterology, vol. 109, no. 6, pp. 887–894, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. M. A. Levitt, K. L. Mathis, and J. H. Pemberton, “Surgical treatment for constipation in children and adults,” Best Practice and Research: Clinical Gastroenterology, vol. 25, no. 1, pp. 167–179, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. V. C. Wasinger, S. J. Cordwell, A. Cerpa-Poljak et al., “Progress with gene-product mapping of the Mollicutes: Mycoplasma genitalium,” Electrophoresis, vol. 16, no. 7, pp. 1090–1094, 1995. View at Publisher · View at Google Scholar · View at Scopus
  13. A. J. Ferreri, G. Illerhaus, E. Zucca, F. Cavalli, and International Extranodal Lymphoma Study Group, “Flows and flaws in primary central nervous system lymphoma,” Nature Reviews Clinical Oncology, vol. 7, no. 8, 2010. View at Publisher · View at Google Scholar
  14. A. Vaiopoulou, M. Gazouli, G. Theodoropoulos, and G. Zografos, “Current advantages in the application of proteomics in inflammatory bowel disease,” Digestive Diseases and Sciences, vol. 57, no. 11, pp. 2755–2764, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. P. P. Chan, V. C. Wasinger, and R. W. Leong, “Current application of proteomics in biomarker discovery for inflammatory bowel disease,” World Journal of Gastrointestinal Pathophysiology, vol. 7, no. 1, pp. 27–37, 2016. View at Google Scholar
  16. Y. Hara, Y. Sassi, C. Guibert et al., “Inhibition of MRP4 prevents and reverses pulmonary hypertension in mice,” The Journal of Clinical Investigation, vol. 121, no. 7, pp. 2888–2897, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. Sassi, L. Lipskaia, G. Vandecasteele et al., “Multidrug resistance-associated protein 4 regulates cAMP-dependent signaling pathways and controls human and rat SMC proliferation,” The Journal of Clinical Investigation, vol. 118, no. 8, pp. 2747–2757, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Wang, F. Li, E. Quan, D. Dong, and B. Wu, “Efflux transport characterization of resveratrol glucuronides in UDP-glucuronosyltransferase 1A1 transfected hela cells: application of a cellular pharmacokinetic model to decipher the contribution of multidrug resistance-associated protein 4,” Drug Metabolism and Disposition, vol. 44, no. 4, pp. 485–488, 2016. View at Publisher · View at Google Scholar
  19. A. Kawase, T. Yamamoto, S. Egashira, and M. Iwaki, “Stereoselective inhibition of methotrexate excretion by glucuronides of nonsteroidal anti-inflammatory drugs via multidrug resistance proteins 2 and 4,” The Journal of Pharmacology and Experimental Therapeutics, vol. 356, no. 2, pp. 366–374, 2016. View at Publisher · View at Google Scholar
  20. X. Zhou, S. Wang, H. Sun, and B. Wu, “Sulfonation of raloxifene in HEK293 cells overexpressing SULT1A3: involvement of breast cancer resistance protein (BCRP/ABCG2) and multidrug resistance-associated protein 4 (MRP4/ABCC4) in excretion of sulfate metabolites,” Drug Metabolism and Pharmacokinetics, vol. 30, no. 6, pp. 425–433, 2015. View at Publisher · View at Google Scholar
  21. W. Lian, X. Liu, L. Yang et al., “The role of TNFalpha in promoting hepatic MRP4 expression via the p38-Rb-E2F1 pathway in human obstructive cholestasis,” Biochemical and Biophysical Research Communications, 2016. View at Google Scholar